| Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study M Arnold, MJ Rutherford, A Bardot, J Ferlay, TML Andersson, ... The Lancet Oncology 20 (11), 1493-1505, 2019 | 884 | 2019 |
| Transanal total mesorectal excision for rectal cancer has been suspended in Norway HH Wasmuth, AE Faerden, TÅ Myklebust, F Pfeffer, S Norderval, R Riis, ... Journal of British Surgery 107 (1), 121-130, 2020 | 226 | 2020 |
| Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010 MG Guren, H Kørner, F Pfeffer, TÅ Myklebust, MT Eriksen, TH Edna, ... Acta Oncologica 54 (10), 1714-1722, 2015 | 94 | 2015 |
| Aspirin as secondary prevention in patients with colorectal cancer: an unselected population-based study SJ Bains, M Mahic, TÅ Myklebust, MC Småstuen, S Yaqub, LM Dørum, ... Journal of clinical oncology 34 (21), 2501-2508, 2016 | 89 | 2016 |
| Lifestyle predictors of successful aging: A 20-year prospective HUNT study I Bosnes, HM Nordahl, E Stordal, O Bosnes, TÅ Myklebust, O Almkvist PloS one 14 (7), e0219200, 2019 | 86 | 2019 |
| Cancer risk in women treated with fertility drugs according to parity status—a registry-based cohort study MM Reigstad, R Storeng, TÅ Myklebust, NB Oldereid, AK Omland, ... Cancer Epidemiology, Biomarkers & Prevention 26 (6), 953-962, 2017 | 85 | 2017 |
| Risk of cancer in children conceived by assisted reproductive technology MM Reigstad, IK Larsen, TÅ Myklebust, TE Robsahm, NB Oldereid, ... Pediatrics 137 (3), 2016 | 83 | 2016 |
| Cancer risk among parous women following assisted reproductive technology MM Reigstad, IK Larsen, TÅ Myklebust, TE Robsahm, NB Oldereid, ... Human reproduction 30 (8), 1952-1963, 2015 | 77 | 2015 |
| A consensus-developed morphological re-evaluation of 196 high-grade gastroenteropancreatic neuroendocrine neoplasms and its clinical correlations H Elvebakken, A Perren, JY Scoazec, LH Tang, B Federspiel, DS Klimstra, ... Neuroendocrinology 111 (9), 883-894, 2021 | 76 | 2021 |
| National early rectal cancer treatment revisited T Stornes, A Wibe, A Nesbakken, TÅ Myklebust, BH Endreseth Diseases of the Colon & Rectum 59 (7), 623-629, 2016 | 75 | 2016 |
| Testicular cancer in the cisplatin era: causes of death and mortality rates in a population-based cohort R Hellesnes, TÅ Myklebust, SD Fosså, RM Bremnes, Á Karlsdottir, ... Journal of Clinical Oncology 39 (32), 3561-3573, 2021 | 67 | 2021 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in N orway MM Reigstad, IK Larsen, TÅ Myklebust, TE Robsahm, NB Oldereid, ... International journal of cancer 136 (5), 1140-1148, 2015 | 66 | 2015 |
| Two countries–two treatment strategies for rectal cancer B Glimelius, TÅ Myklebust, K Lundqvist, A Wibe, MG Guren Radiotherapy and Oncology 121 (3), 357-363, 2016 | 65 | 2016 |
| Long-term relative survival after diagnosis of testicular germ cell tumor Ø Kvammen, TÅ Myklebust, A Solberg, B Møller, OH Klepp, SD Fosså, ... Cancer Epidemiology, Biomarkers & Prevention 25 (5), 773-779, 2016 | 55 | 2016 |
| Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study A Søraas, KT Kalleberg, JA Dahl, CL Søraas, TÅ Myklebust, E Axelsen, ... PloS one 16 (8), e0256142, 2021 | 54 | 2021 |
| Education, income and risk of cancer: results from a Norwegian registry-based study IK Larsen, TÅ Myklebust, R Babigumira, E Vinberg, B Møller, G Ursin Acta Oncologica 59 (11), 1300-1307, 2020 | 50 | 2020 |
| Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era R Hellesnes, Ø Kvammen, TÅ Myklebust, RM Bremnes, Á Karlsdottir, ... International Journal of Cancer 147 (1), 21-32, 2020 | 45 | 2020 |
| MGMT Gene Promoter Methylation Status–Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas LE Johannessen, P Brandal, TÅ Myklebust, S Heim, F Micci, ... Cancer Genomics-Proteomics 15 (6), 437-446, 2018 | 45 | 2018 |
| Incidence and survival of multiple myeloma: a population‐based study of 10 524 patients diagnosed 1982–2017 ØO Langseth, TÅ Myklebust, TB Johannesen, Ø Hjertner, A Waage British journal of haematology 191 (3), 418-425, 2020 | 44 | 2020 |
| Survival in neuroendocrine neoplasms; A report from a large Norwegian population‐based study R Boyar Cetinkaya, B Aagnes, TÅ Myklebust, E Thiis‐Evensen International journal of cancer 142 (6), 1139-1147, 2018 | 43 | 2018 |
